| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Bridgebio Pharma, Inc. (BBIO) has 13 insiders with recent SEC Form 4 filings, including 0 buys and 27 sells. BBIO is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| ? | 18.56M | $1.28B | - | |
| 10% | 14.59M | $1.01B | - | |
| CEO | 4.40M | $303.14M | - | |
| Dir | 916.7K | $63.18M | - | |
| Dir | 766.6K | $52.83M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Apr 27, 2020 | Turtle Cameron | See Remarks | Sale+OE | 2,000 | $32.01 | $64,027.60 | -16.9% | |
| Apr 8, 2020 | Turtle Cameron | See Remarks | Sale+OE | 8,000 | $27.04 | $216,357.60 | -44.9% | |
| Apr 7, 2020 | Kumar Neil | CEO And President | Sell | 1,805 | $25.48 | $45,983.10 | - | |
| Apr 3, 2020 | Kumar Neil | CEO And President | Sell | 300 | $25.09 | $7,528.00 | - | |
| Apr 2, 2020 | Kumar Neil | CEO And President | Sell | 77,895 | $26.02 | $2,026,465.64 | -0.6% | |
| Apr 1, 2020 | Henderson Michael Thomas58 | See Remarks | Sell | 2,585 | $26.94 | $69,629.23 | -0.5% | |
| Apr 1, 2020 | Stephenson Brian C | See Remarks | Sell | 7,200 | $26.61 | $191,609.57 | -0.7% | |
| Mar 3, 2020 | Kumar Neil | CEO And President | Sell | 120,000 | $32.28 | $3,874,030.43 | -0.7% | |
| Mar 2, 2020 | Stephenson Brian C | See Remark | Sell | 10,800 | $32.27 | $348,540.95 | -1.0% | |
| Mar 2, 2020 | Henderson Michael Thomas58 | See Remarks | Sell | 3,975 | $32.44 | $128,965.21 | -1.1% |